Drawing for MOLECULAR DIFFERENTIAL DIAGNOSTICS (MDD)

USPTO serial 78646547

MOLECULAR DIFFERENTIAL DIAGNOSTICS (MDD)

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KIM, YONG OH
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MOLECULAR DIFFERENTIAL DIAGNOSTICS (MDD)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or research use for conducting molecular analysis using target enriched multiplex polymerase chain reaction technology for healthcare, environmental, agricultural, diagnostic, and other applicationsACTIVEJan 7, 2005
042Scientific and technological services, design, and development of computer hardware, computer software, and laboratory instruments using reagents for scientific research use for conducting molecular analysis using target enriched multiplex polymerase chain reaction technology for healthcare, environmental, agricultural, diagnostic, and other applicationsACTIVEJan 7, 2005
044Medical services, diagnostic sample processing services, and assay development using targe enriched multiplex polymerase chain reaction and reporter oligo capture after specific hybridization technologies for detection and identification of viral and bacterial pathogens and mutations associated with various diseasesACTIVEJan 7, 2005

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 21, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 19, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 9, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2005DOCKASSIGNED TO EXAMINER—
Jun 13, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance